TypTap Insurance Company Receives Approval to Write Homeowners Insurance in New Mexico as Part of Company’s Nationwide Expansion Plan
Get Alerts HCI Hot Sheet
Join SI Premium – FREE
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
TAMPA, Fla., Feb. 11, 2021 (GLOBE NEWSWIRE) -- TypTap Insurance Company, a rapidly growing, technology-driven insurance company wholly owned by HCI Group, Inc. (NYSE: HCI), has received regulatory approval to write homeowners insurance in New Mexico.
The approval is part of TypTap’s planned nationwide expansion announced in August of 2020. TypTap has received approvals in ten states outside of Florida.
About HCI Group, Inc.HCI Group, Inc. is an InsurTech company with operations in insurance, software development and real estate. HCI’s leading insurance operation, TypTap Insurance Company, is a rapidly growing, technology-driven insurance company that is expanding nationwide to provide homeowners and flood insurance. TypTap’s operations are powered in large part by insurance-related information technology developed by HCI’s software subsidiary, Exzeo USA, Inc. HCI’s largest subsidiary, Homeowners Choice Property & Casualty Insurance Company, Inc., provides homeowners’ insurance primarily in Florida. HCI’s real estate subsidiary, Greenleaf Capital, LLC, owns and operates multiple properties in Florida, including office buildings, retail centers and marinas.
The company's common shares trade on the New York Stock Exchange under the ticker symbol "HCI" and are included in the Russell 2000 and S&P SmallCap 600 Index. HCI Group, Inc. regularly publishes financial and other information in the Investor Information section of the company’s website. For more information about HCI Group and its subsidiaries, visit www.hcigroup.com.
TypTap Company Contact:Kevin Mitchell, PresidentTypTap Insurance CompanyTel (813) 405-3603kmitchell@typtap.com
TypTap Media Contact:Amber BrinkleyKippen CommunicationsTel (727) 466-7695amber@kippencommunications.com
HCI Company Contact:Rachel Swansiger, Esq. HCI Group, Inc.Tel (813) 405-3206rswansiger@hcigroup.com
HCI Investor Relations Contact:Matt GloverGateway Investor RelationsTel (949) 574-3860HCI@gatewayir.com
Source: HCI Group, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FSIS ISSUES PUBLIC HEALTH ALERT FOR RAW GROUND TURKEY PRODUCTS LINKED TO SALMONELLA HADAR ILLNESS
- C4 Therapeutics Presents Preclinical Data on CFT7455, a Novel IKZF1/3 Degrader for the Treatment of Hematologic Malignancies, at the AACR Annual Meeting 2021
- C4 Therapeutics Presents Preclinical Data on CFT7455, a Novel IKZF1/3 Degrader for the Treatment of Hematologic Malignancies, at the AACR Annual Meeting 2021
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!